|
AERx Inhalation Technology Platform
Liposomal Formulations
 Intellectual Property
|
Aradigm
actively seeks to protect its technologies and products as reflected
in the Company's intellectual property estate. The bulk of the
patents and patent applications contain claims directed toward
the Company's proprietary delivery technologies, including methods
for aerosol generation, devices used to generate aerosols, breath
control, compliance monitoring, certain pharmaceutical formulations,
design of dosage forms and their manufacturing and testing methods.
For certain formulation technologies the Company has in-licensed
some technology and will seek to supplement such intellectual
property rights with complementary proprietary processes, methods,
and formulation technologies through patent applications and
trade secret protection.
|
